首页 › 基金 › Duquesne Family Office LLC › BLTE
Duquesne Family Office LLC 对 BLTE 的持仓历史
BELITE BIO INC · 医疗保健
Duquesne Family Office LLC 在 Q3 2026 的 13F 申报中披露持有 BLTE(BELITE BIO INC)106,100 股,市值约 US$18.0M,约占其申报组合的 0.48%,在其申报持仓中市值排名第 37 位。 Duquesne Family Office LLC 最近 3 个申报季度中有 3 个季度披露了 BLTE 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Duquesne Family Office LLC 对 BLTE 的持仓演变
Duquesne Family Office LLC 于 Q1 2026 首次披露 BLTE 持仓:106,100 股(约 US$16.9M)。 该持仓在 Q3 2026 达到峰值 106,100 股,市值约 US$18.0M。 在 3 次申报中,Duquesne Family Office LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 106,100 股、市值约 US$18.0M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 106.10K | $16.92M | 新进 |
| Q2 2026 | 106.10K | $16.34M | 持有 |
| Q3 2026 | 106.10K | $18.02M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BLTE 与 13F 数据
BLTE(BELITE BIO INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 BLTE,申报仓位最大的包括:Darwin Global Management, Ltd. (US$526.0M), Paradigm Biocapital Advisors LP (US$194.0M), RTW INVESTMENTS, LP (US$121.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BLTE 的基金
- Darwin Global Management, Ltd. 3.10M 股 · $525.95M · Q3 2026
- Paradigm Biocapital Advisors LP 1.14M 股 · $193.96M · Q3 2026
- RTW INVESTMENTS, LP 715.33K 股 · $121.48M · Q3 2026
- MAVERICK CAPITAL LTD 609.91K 股 · $103.57M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 390.83K 股 · $66.37M · Q3 2026
- Maverick 资本 396.31K 股 · $61.03M · Q2 2026
- Affinity Asset Advisors, LLC 242.09K 股 · $41.11M · Q3 2026
- Logos Global Management LP 200.00K 股 · $33.96M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 190.00K 股 · $32.27M · Q3 2026
- MPM BioImpact LLC 133.39K 股 · $22.65M · Q3 2026
- Patient Square Capital LP 131.70K 股 · $22.37M · Q3 2026
- GREAT POINT PARTNERS LLC 75.00K 股 · $12.74M · Q3 2026
更多关于 Duquesne Family Office LLC
常见问题
How long has Duquesne Family Office LLC held BLTE?
Duquesne Family Office LLC has disclosed BLTE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Duquesne Family Office LLC's current position in BLTE?
As of Q3 2026, Duquesne Family Office LLC holds 106.10K shares of BLTE (BELITE BIO INC), valued at $18.02M, representing 0.48% of its reported portfolio and ranking #37.
Has Duquesne Family Office LLC been buying or selling BLTE?
In the latest 13F filing (Q3 2026), Duquesne Family Office LLC held unchanged its position in BLTE. The position peaked in Q3 2026 at 106.10K shares.
Which other funds hold BLTE?
Other major institutional holders of BLTE include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.